Post

Why aren’t eligible sites being utilised in clinical trials?

The perpetual problem of under-recruitment within clinical trials was inevitably discussed between key industry players throughout the 10th annual Outsourcing …

Signal: US lays out plan to seize govt-funded drug patents to lower cost

The Biden administration has announced plans to allow agencies to use march-in rights to seize patents of government-funded drugs if …

BMS’s Opdivo meets co-primary endpoint in colorectal cancer trial  

Bristol Myers Squibb (BMS) has announced that the Phase III CheckMate-8HW trial investigating Opdivo (nivolumab) with Yervoy (ipilimumab) to treat …

Pfizer’s multiple myeloma treatment secures conditional approval in EU

Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional market approval from the European Commission (EC), following a Phase …

Kymera’s protein degrader starts Phase II trial in atopic dermatitis

Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial evaluating KT-474 in patients with atopic dermatitis …